Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
Muhammad Abbas(Nanjing University), Hai‐Liang Zhu(Nanjing University), Murad Habib(Jatiya Kabi Kazi Nazrul Islam University), Yiqiao Hu(Pharmaceutical Biotechnology (Czechia)), Meiqi Shi(Jiangsu Cancer Hospital), Zhong‐Chang Wang(Nanjing University), Said Abasse Kassim(Southeast University), Xiaoyou Li(Jiangsu Cancer Hospital)
Cited by 26
Related Papers
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
|Journal of Clinical Oncology|2022|177
TRPM8 channels: A review of distribution and clinical role
|European Journal of Pharmacology|2020|114
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
Drinking-water nitrate and cancer risk: A systematic review and meta-analysis
|Archives of Environmental & Occupational Health|2020|100
Nanoscale Metal–Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy
|ACS Applied Materials & Interfaces|2019|95